#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	368	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1360	19.8	0	.	p	.	0	K29T	NONSYN	85	87	AAG	444	446	ACG	29;29;26	A;C;G	29;29;26	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	16	Enterobacter_aerogenes_omp36	1128	116	91.38	Enterobacter_aerogenes_omp36.l6.c4.ctg.1	140	4.7	0	.	p	.	0	G319D	NONSYN	955	957	GGC	3	5	GAC	2;3;3	G;A;C	2;3;3	.	Enterobacter aerogenes omp36 mutants
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	16	Enterobacter_aerogenes_omp36	1128	116	91.38	Enterobacter_aerogenes_omp36.l6.c4.ctg.1	140	4.7	0	.	p	.	0	Q321E	NONSYN	961	963	CAG	9	11	GAA	3;4;4	G;A;A	3;4;4	.	Enterobacter aerogenes omp36 mutants
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	16	Enterobacter_aerogenes_omp36	1128	116	91.38	Enterobacter_aerogenes_omp36.l6.c4.ctg.1	140	4.7	0	.	p	.	0	L329V	NONSYN	985	987	CTG	33	35	GTT	5;5;5	G;T;T	5;5;5	.	Enterobacter aerogenes omp36 mutants
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	16	Enterobacter_aerogenes_omp36	1128	116	91.38	Enterobacter_aerogenes_omp36.l6.c4.ctg.1	140	4.7	0	.	p	.	0	K354Q	NONSYN	1060	1062	AAG	108	110	CAG	4;4;4	C;A;G	4;4;4	.	Enterobacter aerogenes omp36 mutants
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	L121Q	0	.	.	361	363	CTG	547	549	CTG	88;87;87	C;T;G	88;86;86	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	Q125K	0	.	.	373	375	CAG	559	561	CAG	89;91;89	C;A;G	87;89;89	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	Q125R	0	.	.	373	375	CAG	559	561	CAG	89;91;89	C;A;G	87;89;89	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	Q125E	0	.	.	373	375	CAG	559	561	CAG	89;91;89	C;A;G	87;89;89	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	Y161C	0	.	.	481	483	TAC	667	669	TAC	79;80;79	T;A;C	78;79;78	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	Y161N	0	.	.	481	483	TAC	667	669	TAC	79;80;79	T;A;C	78;79;78	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	Y161D	0	.	.	481	483	TAC	667	669	TAC	79;80;79	T;A;C	78;79;78	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	G317D	0	.	.	949	951	GGC	1135	1137	GGC	74;74;74	G;G;C	74;74;73	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1312	1314	GCA	43;42;43	G;C;A	41;40;42	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1312	1314	GCA	43;42;43	G;C;A	41;40;42	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1321	1323	GAA	42;42;43	G;A;A	42;42;43	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	1164	99.4	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1351	63.2	0	HET	.	.	.	C210T	.	210	210	C	396	396	C	76	C,T	43,32	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	118	100.0	Escherichia_coli_EF_Tu.l6.c30.ctg.2	425	12.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	93	100.0	Escherichia_coli_EF_Tu.l6.c30.ctg.3	212	8.7	1	SNP	p	A376V	0	.	.	1126	1128	GCA	34	36	GCA	8;8;8	G;C;A	5;5;5	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	93	100.0	Escherichia_coli_EF_Tu.l6.c30.ctg.3	212	8.7	1	SNP	p	A376S	0	.	.	1126	1128	GCA	34	36	GCA	8;8;8	G;C;A	5;5;5	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	93	100.0	Escherichia_coli_EF_Tu.l6.c30.ctg.3	212	8.7	1	SNP	p	E379K	0	.	.	1135	1137	GAA	43	45	GAA	8;7;7	G;A;A	5;5;5	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	93	96.77	Escherichia_coli_EF_Tu.l6.c30.ctg.4	353	12.3	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	88	90	AGC	12;13;14	A;G;C	12;13;14	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	93	96.77	Escherichia_coli_EF_Tu.l6.c30.ctg.4	353	12.3	1	SNP	p	A376V	0	.	.	1126	1128	GCA	34	36	GCA	14;14;14	G;C;A	4;4;4	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	93	96.77	Escherichia_coli_EF_Tu.l6.c30.ctg.4	353	12.3	1	SNP	p	A376S	0	.	.	1126	1128	GCA	34	36	GCA	14;14;14	G;C;A	4;4;4	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	1354	Escherichia_coli_EF_Tu	1185	93	96.77	Escherichia_coli_EF_Tu.l6.c30.ctg.4	353	12.3	1	SNP	p	E379K	0	.	.	1135	1137	GAA	43	45	GAA	12;11;11	G;A;A	4;4;4	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	696	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1998	25.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1656	1658	AAA	17;15;15	A;A;A,G	17;15;14,1	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	792	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1742	33.0	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1258	1260	GAA	48;47;48	G;A;A	48;47;48	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	208	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	899	16.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	181	92.82	Pasteurella_multocida_16S.l15.c30.ctg.1	181	37.7	0	.	n	.	0	C990G	SNP	990	990	C	56	56	G	40	G	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	181	92.82	Pasteurella_multocida_16S.l15.c30.ctg.1	181	37.7	0	.	n	.	0	T1002A	SNP	1002	1002	T	68	68	A	43	A	43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	181	92.82	Pasteurella_multocida_16S.l15.c30.ctg.1	181	37.7	0	.	n	.	0	A1004G	SNP	1004	1004	A	70	70	G	42	G	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	181	92.82	Pasteurella_multocida_16S.l15.c30.ctg.1	181	37.7	0	.	n	.	0	C1011T	SNP	1011	1011	C	77	77	T	36	T	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	181	92.82	Pasteurella_multocida_16S.l15.c30.ctg.1	181	37.7	0	.	n	.	0	C1023A	SNP	1023	1023	C	89	89	A	49	A	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	181	92.82	Pasteurella_multocida_16S.l15.c30.ctg.1	181	37.7	0	.	n	.	0	T1024A	SNP	1024	1024	T	90	90	A	49	A	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	181	92.82	Pasteurella_multocida_16S.l15.c30.ctg.1	181	37.7	0	.	n	.	0	T1041G	SNP	1041	1041	T	107	107	G	52	G	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	181	92.82	Pasteurella_multocida_16S.l15.c30.ctg.1	181	37.7	0	.	n	.	0	A1042T	SNP	1042	1042	A	108	108	T	54	T	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	A1136G	SNP	1136	1136	A	95	95	G	126	G,T	124,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	T1138C	SNP	1138	1138	T	97	97	C	128	C	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	T1142C	SNP	1142	1142	T	101	101	C	135	C	131	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	C1170T	SNP	1170	1170	C	129	129	T	163	T	162	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	T1220C	SNP	1220	1220	T	179	179	C	157	C	156	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	T1245C	SNP	1245	1245	T	204	204	C	150	C	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	G1253A	SNP	1253	1253	G	212	212	A	130	A	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	G1256A	SNP	1256	1256	G	215	215	A	124	A	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	C1258A	SNP	1258	1258	C	217	217	A	123	A	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	G1266T	SNP	1266	1266	G	225	225	T	116	T	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	T1267C	SNP	1267	1267	T	226	226	C	114	C	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	T1275C	SNP	1275	1275	T	234	234	C	120	C	119	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	G1276A	SNP	1276	1276	G	235	235	A	119	A	118	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	A1281G	SNP	1281	1281	A	240	240	G	127	G,C	126,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	T1283C	SNP	1283	1283	T	242	242	C	132	C	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	G1288T	SNP	1288	1288	G	247	247	T	143	TAAA,TAA	136,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	A1296G	SNP	1296	1296	A	255	255	G	152	G	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	T1299G	SNP	1299	1299	T	258	258	G	148	G,T	146,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	A1300T	SNP	1300	1300	A	259	259	T	149	T	148	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	C1356T	SNP	1356	1356	C	315	315	T	190	T	190	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	A1358G	SNP	1358	1358	A	317	317	G	189	G	188	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	T1368C	SNP	1368	1368	T	327	327	C	177	C	175	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	G1370A	SNP	1370	1370	G	329	329	A	171	A	169	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	C1406.	DEL	1406	1406	C	364	364	C	104	C	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	.1409C	INS	1409	1409	T	368	368	C	91	C	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	C1431A	SNP	1431	1431	C	390	390	A	70	A	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	C1432A	SNP	1432	1432	C	391	391	A	70	A	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	A1441G	SNP	1441	1441	A	400	400	G	89	G	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	T1464C	SNP	1464	1464	T	423	423	C	82	C	82	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	G1473T	SNP	1473	1473	G	432	432	T	105	T	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	A1475G	SNP	1475	1475	A	434	434	G	107	G	107	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	0	.	n	.	0	A1548T	SNP	1548	1548	A	507	507	T	88	T	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.4	543	132.7	1	SNP	n	C1194G	0	.	.	1194	1194	C	153	153	C	174	C	173	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	187	92.55	Pasteurella_multocida_16S.l15.c30.ctg.5	187	44.0	0	.	n	.	0	C990G	SNP	990	990	C	62	62	G	32	G	27	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	187	92.55	Pasteurella_multocida_16S.l15.c30.ctg.5	187	44.0	0	.	n	.	0	T1002A	SNP	1002	1002	T	74	74	A	28	A,C	27,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	187	92.55	Pasteurella_multocida_16S.l15.c30.ctg.5	187	44.0	0	.	n	.	0	A1003C	SNP	1003	1003	A	75	75	C	23	C	23	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	187	92.55	Pasteurella_multocida_16S.l15.c30.ctg.5	187	44.0	0	.	n	.	0	G1008C	SNP	1008	1008	G	80	80	C	25	C	25	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	187	92.55	Pasteurella_multocida_16S.l15.c30.ctg.5	187	44.0	0	.	n	.	0	C1011T	SNP	1011	1011	C	83	83	T	26	T	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	187	92.55	Pasteurella_multocida_16S.l15.c30.ctg.5	187	44.0	0	.	n	.	0	T1012C	SNP	1012	1012	T	84	84	C	26	C,T	25,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	187	92.55	Pasteurella_multocida_16S.l15.c30.ctg.5	187	44.0	0	.	n	.	0	C1023A	SNP	1023	1023	C	94	94	A	34	A	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	187	92.55	Pasteurella_multocida_16S.l15.c30.ctg.5	187	44.0	0	.	n	.	0	.1025G	INS	1025	1025	T	97	97	G	36	G	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	187	92.55	Pasteurella_multocida_16S.l15.c30.ctg.5	187	44.0	0	.	n	.	0	T1041G	SNP	1041	1041	T	113	113	G	54	G	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	1980	Pasteurella_multocida_16S	1551	187	92.55	Pasteurella_multocida_16S.l15.c30.ctg.5	187	44.0	0	.	n	.	0	A1042T	SNP	1042	1042	A	114	114	T	55	T	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	514	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1515	25.2	0	.	p	.	0	H2R	NONSYN	4	6	CAT	243	245	CGT	23;24;25	C;G;T	23;24;25	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	514	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1515	25.2	0	.	p	.	0	V30I	NONSYN	88	90	GTC	327	329	ATC	27;27;27	A;T;C	27;27;26	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	514	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1515	25.2	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1086	1088	GGC	31;31;31	G;G;C	31;30;31	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	884	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2186	29.6	0	.	p	.	0	R8S	NONSYN	22	24	AGA	296	298	AGC	17;17;17	A;G;C	17;17;17	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	884	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2186	29.6	0	.	p	.	0	I142L	NONSYN	424	426	ATA	698	700	CTA	31;31;33	C;T;A	31;31;33	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	884	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2186	29.6	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1217	1219	CAA	40;40;40	C;A;A	40;40;40	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	884	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2186	29.6	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1316	1318	GGT	52;51;51	G;G;T	52;51;51	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	884	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2186	29.6	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1886	1888	GTT	26;24;24	G;T;T	26;24;24	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	380	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1733	16.3	0	.	p	.	0	A125E	NONSYN	373	375	GCA	628	630	GAA	15;15;15	G;A;A	15;15;15	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	380	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1733	16.3	0	.	p	.	0	M185T	NONSYN	553	555	ATG	808	810	ACC	14;15;15	A;C;C	14;15;15	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	380	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1733	16.3	0	.	p	.	0	S225T	NONSYN	673	675	TCC	928	930	ACT	10;10;9	A;C;T	10;10;9	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	380	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1733	16.3	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1318	1320	ATC	11;11;11	A;T;C	11;11;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	1	556	PmrF	969	364	99.73	PmrF.l15.c17.ctg.1	840	18.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	1	556	PmrF	969	614	99.19	PmrF.l15.c17.ctg.2	1212	20.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_123.3000985.AY327539.0_858.1321	TEM_123.3000985.AY327539.0_858.1321	1	0	16	16	TEM_1+	858	159	100.0	TEM_1+.l15.c4.ctg.1	159	1.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-123 is an extended-spectrum beta-lactamase found in Proteus mirabilis.;TEM-123
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	266	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1197	15.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1638	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3695	32.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	536	538	ATC	40;40;41	A;T;C	40;40;41	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1638	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3695	32.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2249	2251	AAG	25;23;22	A;A;G	25;23;22	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	618	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1630	27.8	0	.	p	.	0	A22V	NONSYN	64	66	GCC	237	239	GTC	13;13;11	G;T;C	13;13;11	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	618	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1630	27.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	978	980	TGC	42;41;42	T;G;C	42;41;42	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1346	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3423	29.1	0	.	p	.	0	S46trunc	TRUNC	136	136	T	516	516	T	22	T	22	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1346	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3423	29.1	0	.	p	.	0	G148D	NONSYN	442	444	GGC	822	824	GAC	34;34;34	G;A;C	34;34;34	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1346	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3423	29.1	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1098	1100	TTA	27;24;25	T;T;A	27;24;25	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1346	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3423	29.1	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1281	1283	AAT	25;24;23	A;A;T	25;23;23	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1346	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	3423	29.1	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	2068	2068	T	35	T	35	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	392	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1274	22.7	1	SNP	p	R45C	0	.	.	133	135	CGC	478	480	CGC	43;45;44	C;G;C	43;45;44	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	250	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1054	17.0	0	.	p	.	0	L34F	NONSYN	100	102	CTC	278	280	TTC	19;19;20	T;T;C	19;19;20	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	250	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1054	17.0	0	.	p	.	0	E122G	NONSYN	364	366	GAG	542	544	GGG	21;21;21	G;G;G	21;21;21	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	318	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1274	18.5	0	.	p	.	0	V136L	NONSYN	406	408	GTT	547	549	CTT	25;25;26	C;T;T	25;25;26	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1374	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3106	32.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2060	2062	GCA	50;50;50	G;C;A	49;50;50	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1374	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3106	32.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2321	2323	ACC	36;36;38	A;C;C	35;36;38	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1374	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3106	32.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2630	2632	GCC	49;49;49	G;C;C	49;47;48	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	878	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2509	25.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	326	328	GCT	22;22;22	G;C;T	22;22;22	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	878	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2509	25.9	0	.	p	.	0	D77E	NONSYN	229	231	GAT	446	448	GAG	27;27;27	G;A;G	27;27;27	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	878	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2509	25.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	482	484	TGC	23;24;24	T;G;C	23;24;24	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	878	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2509	25.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	665	667	GTT	28;27;29	G;T;T	27;26;28	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	878	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2509	25.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	815	817	CAC	29;31;30	C;A;C	29;31;30	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	878	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2509	25.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1100	1102	ATG	29;29;29	A;T;G	28;28;28	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	878	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2509	25.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2096	2098	CGC	36;36;37	C;G;C	36;36;36	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	432	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1390	22.9	0	.	p	.	0	S221T	NONSYN	661	663	AGC	999	1001	ACC	20;20;20	A;C;C	20;20;20	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	432	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1390	22.9	0	.	p	.	0	P225S	NONSYN	673	675	CCG	1011	1013	TCG	22;22;23	T;C;G	22;22;23	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	422	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1512	20.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	560	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1917	21.4	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1371	1373	AAA	18;18;17	A;A;A	18;18;17	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	560	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1917	21.4	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1383	1385	GAG	15;14;14	G;A;G	15;14;14	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	560	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1917	21.4	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1389	1391	CAC	13;13;13	C;A;C	13;13;13	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	560	baeS	1404	1404	98.86	baeS.l6.c4.ctg.1	1917	21.4	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1443	1445	GAG	11;11;11	G;A;G	11;11;11	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	654	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1914	24.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	462	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1264	27.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	438	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1483	21.5	0	.	p	.	0	A146T	NONSYN	436	438	GCT	730	732	ACT	27;27;27	A;C;T	27;27;27	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	106	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	771	10.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	590	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1806	24.1	0	.	p	.	0	I219V	NONSYN	655	657	ATC	1007	1009	GTC	36;36;37	G;T;C	34;35;36	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	818	emrB	1539	1539	99.74	emrB.l6.c17.ctg.1	2201	27.3	0	.	p	.	0	E197K	NONSYN	589	591	GAA	969	971	AAA	33;34;33	A;A;A	32;33;32	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	638	emrD	1191	1191	98.4	emrD.l15.c17.ctg.1	1780	26.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	940	942	AGC	48;48;49	A;G;C	48;48;49	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	19	40	emrE_1	333	296	93.92	emrE_1.l15.c30.ctg.1	370	6.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	424	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1742	18.1	0	.	p	.	0	K176R	NONSYN	526	528	AAG	835	837	AGG	26;28;29	A;G;G	26;28;29	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	424	emrK	1056	1056	98.2	emrK.l6.c4.ctg.1	1742	18.1	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1225	1227	GAC	23;23;23	G;A;C	23;23;23	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	202	emrR	531	531	100.0	emrR.l15.c17.ctg.1	1094	13.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	638	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2080	22.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	226	evgA	615	615	99.19	evgA.l6.c17.ctg.1	1187	14.1	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	437	439	CTG	16;16;16	C;T;G	16;16;16	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	T38I	NONSYN	112	114	ACA	410	412	ATA	17;17;17	A;T;A	17;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	L42V	NONSYN	124	126	CTA	422	424	GTA	15;15;16	G;T;A	15;15;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	A93T	NONSYN	277	279	GCG	575	577	ACG	19;19;19	A;C;G	18;18;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	A114E	NONSYN	340	342	GCA	638	640	GAA	17;17;17	G;A;A	17;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	T127A	NONSYN	379	381	ACT	677	679	GCT	14;15;15	G;C;T	14;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	N133D	NONSYN	397	399	AAT	695	697	GAT	13;12;12	G;A;T	13;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	P162S	NONSYN	484	486	CCA	782	784	TCA	13;13;13	T;C;A	13;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	911	913	CAG	12;12;12	C;A;G	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1049	1051	GTT	16;16;16	G;T;T	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1205	1207	GAT	15;16;16	G;A;T	15;16;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1373	1375	AAT	10;11;11	A;A;T	10;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1394	1396	TTA	7;7;8	T;T;A	7;7;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1595	1597	AAA	17;16;16	A;A;A	17;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2330	2332	CAT	16;16;16	C;A;T	15;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2384	2386	CAT	20;20;20	C;A;T	20;20;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2402	2404	AGA	15;15;14	A,G;G;A	14,1;15;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2417	2419	AAT	14;14;13	A;A;T	14;14;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2564	2566	TCC	23;23;24	T;C;C	22;22;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2729	2731	ATT	20;19;19	A;T;T	20;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2750	2752	GAT	22;22;22	G;A;T	22;22;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2864	2866	GTT	25;23;21	G;T;T	25;23;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1200	evgS	3594	3594	97.52	evgS.l6.c30.ctg.1	4106	21.8	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3149	3151	CAC	39;39;40	C;A;C	38;38;39	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	496	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1512	24.3	1	SNP	p	P64H	0	.	.	190	192	CCA	522	524	CCA	50;49;50	C;C;A	50;48;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	496	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1512	24.3	1	SNP	p	P64R	0	.	.	190	192	CCA	522	524	CCA	50;49;50	C;C;A	50;48;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	496	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1512	24.3	1	SNP	p	P64A	0	.	.	190	192	CCA	522	524	CCA	50;49;50	C;C;A	50;48;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	496	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1512	24.3	1	SNP	p	P64S	0	.	.	190	192	CCA	522	524	CCA	50;49;50	C;C;A	50;48;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	496	folP_1	849	849	99.29	folP_1.l6.c30.ctg.1	1512	24.3	1	SNP	p	P64L	0	.	.	190	192	CCA	522	524	CCA	50;49;50	C;C;A	50;48;45	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	278	gadE	528	528	100.0	gadE.l15.c4.ctg.1	1185	17.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	58	gadW	729	574	94.25	gadW.l15.c4.ctg.1	607	7.1	0	.	p	.	0	E54D	NONSYN	160	162	GAA	5	7	GAT	1;1;1	G;A;T	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	58	gadW	729	574	94.25	gadW.l15.c4.ctg.1	607	7.1	0	.	p	.	0	I88M	NONSYN	262	264	ATA	107	109	ATG	6;6;6	A;T;G	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	58	gadW	729	574	94.25	gadW.l15.c4.ctg.1	607	7.1	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	110	112	CCG	6;6;6	C;C;G	6;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	58	gadW	729	574	94.25	gadW.l15.c4.ctg.1	607	7.1	0	.	p	.	0	D100E	NONSYN	298	300	GAC	143	145	GAA	3;3;3	G;A;A	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	58	gadW	729	574	94.25	gadW.l15.c4.ctg.1	607	7.1	0	.	p	.	0	P101S	NONSYN	301	303	CCC	146	148	TCC	3;3;3	T;C;C	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	58	gadW	729	574	94.25	gadW.l15.c4.ctg.1	607	7.1	0	.	p	.	0	R102G	NONSYN	304	306	CGG	149	151	GGG	3;2;2	G;G;G	3;2;2	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	58	gadW	729	574	94.25	gadW.l15.c4.ctg.1	607	7.1	0	.	p	.	0	K110N	NONSYN	328	330	AAA	173	175	AAT	5;5;5	A;A;T	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	58	gadW	729	574	94.25	gadW.l15.c4.ctg.1	607	7.1	0	.	p	.	0	S234A	NONSYN	700	702	TCG	545	547	GCG	5;5;5	G;C;G	5;5;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	276	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1208	16.5	0	.	p	.	0	F53L	NONSYN	157	159	TTC	312	314	TTA	14;14;12	T;T;A	14;14;12	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	276	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1208	16.5	0	.	p	.	0	V79I	NONSYN	235	237	GTT	390	392	ATT	19;20;20	A;T;T	19;19;20	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	276	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1208	16.5	0	.	p	.	0	R246G	NONSYN	736	738	AGA	891	893	GGA	18;18;17	G;G;A	18;18;17	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	276	gadX	825	825	97.94	gadX.l6.c4.ctg.1	1208	16.5	0	.	p	.	0	S248P	NONSYN	742	744	TCG	897	899	CCG	19;19;20	C;C;G	19;19;20	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1448	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3208	33.4	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2252	2254	GAA	29;28;29	G;A;A	29;28;29	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1448	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3208	33.4	1	SNP	p	S83I	0	.	.	247	249	TCG	467	469	TCG	38;37;38	T;C;G	37;37;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1448	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3208	33.4	1	SNP	p	S83W	0	.	.	247	249	TCG	467	469	TCG	38;37;38	T;C;G	37;37;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1448	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3208	33.4	1	SNP	p	S83L	0	.	.	247	249	TCG	467	469	TCG	38;37;38	T;C;G	37;37;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1448	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3208	33.4	1	SNP	p	D87V	0	.	.	259	261	GAC	479	481	GAC	39;39;39	G;A;C	39;39;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1448	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3208	33.4	1	SNP	p	D87H	0	.	.	259	261	GAC	479	481	GAC	39;39;39	G;A;C	39;39;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1448	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3208	33.4	1	SNP	p	D87Y	0	.	.	259	261	GAC	479	481	GAC	39;39;39	G;A;C	39;39;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1448	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3208	33.4	1	SNP	p	D87G	0	.	.	259	261	GAC	479	481	GAC	39;39;39	G;A;C	39;39;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1448	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3208	33.4	1	SNP	p	D87N	0	.	.	259	261	GAC	479	481	GAC	39;39;39	G;A;C	39;39;38	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1114	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2710	29.9	1	SNP	p	R136L	0	.	.	406	408	CGC	548	550	CGC	28;28;28	C;G;C	28;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1114	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2710	29.9	1	SNP	p	R136I	0	.	.	406	408	CGC	548	550	CGC	28;28;28	C;G;C	28;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1114	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2710	29.9	1	SNP	p	R136C	0	.	.	406	408	CGC	548	550	CGC	28;28;28	C;G;C	28;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1114	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2710	29.9	1	SNP	p	R136G	0	.	.	406	408	CGC	548	550	CGC	28;28;28	C;G;C	28;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1114	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2710	29.9	1	SNP	p	R136E	0	.	.	406	408	CGC	548	550	CGC	28;28;28	C;G;C	28;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1114	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2710	29.9	1	SNP	p	R136H	0	.	.	406	408	CGC	548	550	CGC	28;28;28	C;G;C	28;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1114	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2710	29.9	1	SNP	p	R136S	0	.	.	406	408	CGC	548	550	CGC	28;28;28	C;G;C	28;28;27	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	280	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1172	17.2	0	.	p	.	0	A72P	NONSYN	214	216	GCG	587	589	CCG	31;32;32	C;C;G	31;32;32	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	280	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1172	17.2	0	.	p	.	0	T123A	NONSYN	367	369	ACC	740	742	GCC	22;22;22	G,A;C;C	21,1;22;22	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	462	leuO	945	945	99.26	leuO.l6.c30.ctg.1	1372	24.9	0	.	p	.	0	P9S	NONSYN	25	27	CCA	220	222	TCA	28;27;27	T;C;A	28;27;27	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	208	marA	384	384	99.74	marA.l15.c4.ctg.1	970	16.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	533	535	AGC	19;20;21	A;G;C	19;20;21	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	635	637	CAT	13;13;13	C;A;T	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	V45E	0	.	.	133	135	GTG	359	361	GTG	17;17;18	G;T;G	17;17;18	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	I49S	0	.	.	145	147	ATC	371	373	ATC	22;22;19	A;T;C	22;21;19	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	A70T	0	.	.	208	210	GCA	434	436	GCA	19;20;22	G;C;A	19;19;22	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	R73C	0	.	.	217	219	CGT	443	445	CGT	21;21;21	C;G;T	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	R73S	0	.	.	217	219	CGT	443	445	CGT	21;21;21	C;G;T	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	R77L	0	.	.	229	231	CGC	455	457	CGC	20;20;20	C;G;C	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	R77C	0	.	.	229	231	CGC	455	457	CGC	20;20;20	C;G;C	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	L78M	0	.	.	232	234	CTG	458	460	CTG	20;20;19	C;T;G	20;20;19	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	R94H	0	.	.	280	282	CGC	506	508	CGC	23;23;23	C;G;C	22;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	R94S	0	.	.	280	282	CGC	506	508	CGC	23;23;23	C;G;C	22;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	154	marR	435	435	97.7	marR.l6.c4.ctg.1	941	12.0	1	SNP	p	V96E	0	.	.	286	288	GTA	512	514	GTA	22;23;22	G;T;A	20;22;21	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	S7F	NONSYN	19	21	TCC	333	335	TTC	20;20;21	T;T;C	20;20;21	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	R36I	NONSYN	106	108	AGG	420	422	ATC	10;8;8	A;T;C	10;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	E42A	NONSYN	124	126	GAA	438	440	GCC	8;8;9	G;C;C	8;8;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	N43V	NONSYN	127	129	AAT	441	443	GTG	12;12;12	G;T;G	12;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	E52D	NONSYN	154	156	GAG	468	470	GAT	12;11;11	G;A;T	12;11;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	N59T	NONSYN	175	177	AAC	489	491	ACC	14;15;15	A;C;C	14;15;15	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	I68L	NONSYN	202	204	ATA	516	518	TTA	16;12;12	T;T;A	16;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	657	659	CAG	27;29;30	C;A;G	27;28;30	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	D128A	NONSYN	382	384	GAC	696	698	GCC	33;33;32	G;C;C	33;33;31	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	S163A	NONSYN	487	489	TCG	801	803	GCG	50;49;49	G;C;G	50;48;49	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	L231V	NONSYN	691	693	CTT	1005	1007	GTT	43;43;42	G;T;T	36;37;38	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	530	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1887	20.6	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1167	1167	C	28	C	28	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	428	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1880	16.8	0	.	p	.	0	V12trunc	TRUNC	34	34	G	334	334	G	15	G	15	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	428	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1880	16.8	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	391	393	CAG	15;15;15	C;A;G	15;15;15	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	428	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1880	16.8	0	.	p	.	0	T83I	NONSYN	247	249	ACC	541	543	ATC	14;14;14	A;T;C	14;14;14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	428	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1880	16.8	0	.	p	.	0	I99M	NONSYN	295	297	ATA	589	591	ATG	12;12;12	A;T;G	12;12;12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	428	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1880	16.8	0	.	p	.	0	A130T	NONSYN	388	390	GCC	682	684	ACC	17;16;15	A;C;C	17;16;15	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	428	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1880	16.8	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1063	1065	ACG	17;17;17	A;C;G	17;17;17	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1682	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3714	33.4	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2089	2091	ACC	41;41;41	A;C;C	41;41;40	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1682	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3714	33.4	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2482	2484	CAA	38;35;35	C;A;A	37;35;35	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1682	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3714	33.4	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2650	2652	ATT	25;25;25	A;T;T	25;25;24	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1682	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3714	33.4	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2734	2736	GTT	22;21;21	G;T;T	22;21;21	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1682	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3714	33.4	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2842	2844	GAG	38;39;39	G;A;G	37;38;39	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1682	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3714	33.4	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3070	3072	ATG	35;36;36	A;T;G	35;36;36	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1682	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3714	33.4	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3205	3207	GAT	40;41;40	G;A;T	40;41;40	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1566	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3565	32.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	353	355	ATG	25;25;26	A;T;G	25;25;26	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1566	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3565	32.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	839	841	ATC	40;40;40	A;T;C	40;40;40	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1566	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3565	32.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3155	3157	CAC	17;16;16	C;A,C;C	16;15,1;16	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1566	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3565	32.2	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3158	3160	CTC	16;15;16	C;T;C	15;15;16	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	770	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1988	28.5	0	.	p	.	0	D3E	NONSYN	7	9	GAT	321	323	GAA	12;12;12	G;A;A	12;12;12	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	770	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1988	28.5	0	.	p	.	0	T226A	NONSYN	676	678	ACG	990	992	GCG	31;31;30	G;C;G	31;31;30	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	770	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1988	28.5	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1332	1334	ATC	45;47;47	A;T;C	44;47;47	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	770	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1988	28.5	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1635	1637	TTT	34;35;35	T;T;T	34;34;34	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	666	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1831	26.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1436	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3762	28.4	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1207	1209	ACC	29;29;29	A;C;C	29;29;29	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1436	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3762	28.4	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2449	2451	GAC	37;36;36	G;A;C	37;36;36	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	524	mdtG	1227	164	100.0	mdtG.l6.c4.ctg.2	238	12.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	524	mdtG	1227	1047	99.33	mdtG.l6.c4.ctg.3	1662	20.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	727	729	ATC	24;24;25	A;T;C	24;24;25	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	548	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1752	23.0	0	.	p	.	0	G134C	NONSYN	400	402	GGT	632	634	TGT	29;30;30	T;G;T	29;30;30	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	548	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1752	23.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1202	1204	TTG	28;28;28	T;T;G	28;28;28	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	548	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1752	23.0	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1412	1414	ACG	10;9;8	A;C;G	10;9;8	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	642	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1922	24.6	0	.	p	.	0	A185S	NONSYN	553	555	GCC	925	927	TCC	29;29;28	T;C;C	28;29;28	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	478	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1733	20.3	0	.	p	.	0	V119I	NONSYN	355	357	GTT	655	657	ATT	19;19;19	A;T;T	19;19;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	V11M	NONSYN	31	33	GTG	262	264	ATG	14;14;14	A;T;G	14;14;14	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	T33I	NONSYN	97	99	ACC	328	330	ATC	23;24;24	A;T;C	23;23;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	C116R	NONSYN	346	348	TGC	577	579	CGC	29;28;28	C;G;C	29;28;28	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	N238S	NONSYN	712	714	AAC	943	945	AGC	29;29;30	A;G;C	29;29;30	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1144	1146	GTG	28;28;27	G;T;G	28;27;27	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1207	1209	AAC	7;7;7	A;A;C	5;6;6	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1252	1254	GTC	21;21;21	G;T;C	21;21;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1282	1284	ATA	27;27;27	A;T;A	27;26;27	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1390	1392	TCT	23;24;24	T;C;T	23;24;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1777	1779	GCG	29;28;28	G;C;G	29;28;28	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1990	1992	ATC	32;33;32	A;T;C	32;33;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	876	mdtO	2052	2052	98.05	mdtO.l15.c4.ctg.1	2595	25.0	0	.	p	.	0	L601Q	NONSYN	1801	1803	CTG	2032	2034	CAG	29;30;32	C;A;G	29;30;32	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	592	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1895	22.8	0	.	p	.	0	S129A	NONSYN	385	387	TCA	559	561	GCG	29;30;31	G;C;G	29;30;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	592	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1895	22.8	0	.	p	.	0	A187T	NONSYN	559	561	GCC	733	735	ACC	32;32;31	A;C;C	31;31;30	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	592	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1895	22.8	0	.	p	.	0	H211R	NONSYN	631	633	CAC	805	807	CGC	31;31;31	C;G;C	30;31;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	592	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1895	22.8	0	.	p	.	0	V250A	NONSYN	748	750	GTT	922	924	GCT	26;27;26	G;C;T	26;27;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	592	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1895	22.8	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1006	1008	AAA	22;22;22	A;A;A	22;22;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	592	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1895	22.8	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1024	1026	CGA	24;24;25	C;G;A	24;23;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	592	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1895	22.8	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1189	1191	GCC	21;22;22	G;C;C	21;22;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	592	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1895	22.8	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1201	1203	GAT	23;23;22	G;A;T	23;23;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	592	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1895	22.8	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1618	1620	GCT	15;14;13	G;C;T	15;14;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1740	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	4061	31.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1589	1591	AAG	31;33;32	A;A;G	31;32;31	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1740	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	4061	31.7	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2666	2668	CTG	23;22;22	C;T;G	23;20;22	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	160	mgrB	144	144	100.0	mgrB.l15.c4.ctg.1	786	14.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	878	msbA	1749	1749	98.68	msbA.l15.c17.ctg.1	2262	28.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1068	1070	AAC	27;27;28	A;A;C	27;27;28	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	878	msbA	1749	1749	98.68	msbA.l15.c17.ctg.1	2262	28.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1614	1616	ATA	48;47;47	A;T;A	47;47;47	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	708	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1736	30.1	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1345	1347	GAT	54;54;53	G;A;T	54;54;53	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	708	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1736	30.1	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1348	1350	CTG	53;54;52	C;T;G	53;54;52	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	340	nfsA	723	723	98.89	nfsA.l6.c17.ctg.1	1355	18.7	0	.	p	.	0	R27C	NONSYN	79	81	CGT	361	363	TGT	26;27;28	T;G;T	26;27;26	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	340	nfsA	723	723	98.89	nfsA.l6.c17.ctg.1	1355	18.7	0	.	p	.	0	I117T	NONSYN	349	351	ATC	631	633	ACC	36;37;36	A;C;C	36;37;36	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	340	nfsA	723	723	98.89	nfsA.l6.c17.ctg.1	1355	18.7	0	.	p	.	0	G187D	NONSYN	559	561	GGC	841	843	GAC	29;28;27	G;A;C	29;28;27	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	340	nfsA	723	723	98.89	nfsA.l6.c17.ctg.1	1355	18.7	0	.	p	.	0	Y199N	NONSYN	595	597	TAT	877	879	AAT	24;24;24	A,T;A;T	23,1;24;24	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	340	nfsA	723	723	98.89	nfsA.l6.c17.ctg.1	1355	18.7	1	SNP	p	R15C	0	.	.	43	45	CGC	325	327	CGC	31;29;26	C;G;C,G	31;29;25,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	340	nfsA	723	723	98.89	nfsA.l6.c17.ctg.1	1355	18.7	1	SNP	p	S33R	0	.	.	97	99	AGC	379	381	AGC	36;35;35	A;G;C	35;35;35	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	340	nfsA	723	723	98.89	nfsA.l6.c17.ctg.1	1355	18.7	1	SNP	p	G131D	0	.	.	391	393	GGC	673	675	GGC	35;34;35	G;G;C	35;33;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	340	nfsA	723	723	98.89	nfsA.l6.c17.ctg.1	1355	18.7	1	SNP	p	R203C	0	.	.	607	609	CGT	889	891	CGT	23;23;23	C;G;T	23;23;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	340	nfsA	723	723	98.89	nfsA.l6.c17.ctg.1	1355	18.7	1	SNP	p	R203L	0	.	.	607	609	CGT	889	891	CGT	23;23;23	C;G;T	23;23;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	630	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1679	27.6	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1147	1149	GAG	38;37;38	G;A;G	38;37;38	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	630	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1679	27.6	1	SNP	p	G141E	0	.	.	421	423	GGT	634	636	GGT	42;42;43	G;G;T	42;42;43	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	630	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1679	27.6	1	SNP	p	G141D	0	.	.	421	423	GGT	634	636	GGT	42;42;43	G;G;T	42;42;43	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	630	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1679	27.6	1	SNP	p	R154D	0	.	.	460	462	CGT	673	675	CGT	45;45;44	C;G;T	45;45;44	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	630	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1679	27.6	1	SNP	p	R154A	0	.	.	460	462	CGT	673	675	CGT	45;45;44	C;G;T	45;45;44	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1198	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2819	31.1	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1865	1867	GTG	29;30;30	G;T;G	29;30;30	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1198	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2819	31.1	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1892	1894	TCG	33;34;33	T;C;G	30;31;32	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1198	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2819	31.1	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2507	2509	AAC	25;24;24	A;A;C	25;24;24	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1198	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2819	31.1	1	SNP	p	A85T	0	.	.	253	255	GCG	521	523	GCG	38;38;39	G;C;G	38;37;39	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1198	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2819	31.1	1	SNP	p	D111H	0	.	.	331	333	GAT	599	601	GAT	39;39;40	G;A;T	38;39;40	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1198	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2819	31.1	1	SNP	p	S129P	0	.	.	385	387	TCC	653	655	TCC	30;30;30	T,C;C;C	29,1;30;30	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	800	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2614	22.6	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1712	1714	AAC	28;30;29	A;A;C	28;29;29	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	800	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2614	22.6	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1721	1723	GAT	36;35;36	G;A;T	36;35;35	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003317.NC_003197.3343961_3345854.2094	parE.3003317.NC_003197.3343961_3345854.2094	1	1	16	32	parE_2	1893	121	93.39	parE_2.l15.c4.ctg.1	124	5.5	1	SNP	p	V461G	0	.	.	1381	1383	GTG	118	120	GTG	2;2;2	G;T;G	2;2;2	parE.3003317.NC_003197.3343961_3345854.2094:1:1:V461G:.:Point mutation in Salmonella serovars parE resulting in fluoroquinolones resistance	Salmonella serovars parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	732	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1921	27.7	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	858	860	CAG	36;36;36	C;A;G	35;35;35	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	732	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1921	27.7	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1332	1334	GAT	33;33;32	G;A;T	32;32;31	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	V146F	0	.	.	436	438	GTT	786	788	GTT	38;38;38	G;T;T	37;38;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1887	1889	CAG	41;41;41	C;A;G	40;40;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1887	1889	CAG	41;41;41	C;A;G	40;40;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1926	1928	CAC	33;33;32	C;A;C	33;32;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1935	1937	CGT	33;33;32	C;G;T	33;33;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1935	1937	CGT	33;33;32	C;G;T	33;33;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1941	1943	TCC	34;34;34	T;C;C	34;34;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1947	1949	CTC	33;33;32	C;T;C	33;33;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	2037	2039	ACC	35;35;35	A;C;C	35;34;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	2040	2042	CCT	35;34;38	C;C;T	35;34;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2144	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4689	33.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2409	2411	CGT	59;58;58	C;G;T	59;58;58	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	.	n	.	0	A226G	SNP	226	226	A	268	268	G	272	G	271	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	1	SNP	n	A794G	0	.	.	794	794	A	836	836	A	303	A	299	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	1	SNP	n	A794T	0	.	.	794	794	A	836	836	A	303	A	299	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	1	SNP	n	G926C	0	.	.	926	926	G	968	968	G	249	G	247	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	1	SNP	n	G926A	0	.	.	926	926	G	968	968	G	249	G	247	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	1	SNP	n	G926T	0	.	.	926	926	G	968	968	G	249	G	247	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	1	SNP	n	A1519T	0	.	.	1519	1519	A	1561	1561	A	167	A	165	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	1	SNP	n	A1519G	0	.	.	1519	1519	A	1561	1561	A	167	A	165	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	1	SNP	n	A1519C	0	.	.	1519	1519	A	1561	1561	A	167	A	165	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	C183T	.	183	183	C	225	225	C	273	C,T	171,102	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	T90C	.	90	90	T	132	132	T	268	T,C	192,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	A250T	.	250	250	A	292	292	A	244	A,T	188,55	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	G474A	.	474	474	G	516	516	G	250	G,A	184,64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	A253T	.	253	253	A	295	295	A	251	A,T	195,55	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	C194T	.	194	194	C	236	236	C	262	C,T	201,61	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	C719T	.	719	719	C	761	761	C	285	C,T	167,115	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	C680T	.	680	680	C	722	722	C	297	C,T	259,37	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	G1002A	.	1002	1002	G	1044	1044	G	249	G,A	147,101	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	C1038T	.	1038	1038	C	1080	1080	C	285	C,T	169,116	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	G1006C	.	1006	1006	G	1048	1048	G	257	G,C	149,101	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	A79G	.	79	79	A	121	121	A	268	A,G	198,69	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	T273A	.	273	273	T	315	315	T	277	T,A	207,68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	6350	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1598	265.5	0	HET	.	.	.	T1010C	.	1010	1010	T	1052	1052	T	254	T,C	146,105	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	182	sat_1	525	525	100.0	sat_1.l15.c30.ctg.1	942	13.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	376	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1133	24.8	1	SNP	p	R20H	0	.	.	58	60	CGC	428	430	CGC	38;38;40	C;G;C	38;36;39	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	376	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1133	24.8	1	SNP	p	G121D	0	.	.	361	363	GGT	731	733	GGT	27;28;27	G;G;T	27;28;27	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	252	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	963	18.9	1	SNP	p	A12S	0	.	.	34	36	GCA	362	364	GCA	37;37;39	G;C;A	37;37;39	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	232	sul2	816	816	100.0	sul2.l15.c4.ctg.1	1364	12.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	539	348	tet-	1206	1206	99.92	tet-.l15.c4.ctg.1	1482	16.6	0	.	p	.	0	T171A	NONSYN	511	513	ACT	743	745	GCT	14;14;13	G;C;T	14;14;13	.	TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.;tetA
tetC.manually_added_J01830_AAB59095.1_2926_3519	tetC.manually_added_J01830_AAB59095.1_2926_3519	1	0	539	98	tetC	594	594	99.66	tetC.l6.c4.ctg.1	977	7.1	0	.	p	.	0	S152D	NONSYN	454	456	AGT	679	681	GAT	11;11;11	G;A;T	11;11;11	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetD.3000168.BX664015.204137_204554.417	tetD.3000168.BX664015.204137_204554.417	1	0	27	128	tetD	417	417	100.0	tetD.l15.c4.ctg.1	942	9.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tetD;TetD is a tetracycline efflux pump found exclusively in Gram-negative bacteria.
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	230	tetR_2	627	627	100.0	tetR_2.l15.c17.ctg.1	1284	13.1	1	SNP	p	H64Y	0	.	.	190	192	CAC	544	546	CAC	17;17;21	C;A;C	17;17;21	tetR.3003479.AL513383.179218_179845.2090:1:1:H64Y:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	230	tetR_2	627	627	100.0	tetR_2.l15.c17.ctg.1	1284	13.1	1	SNP	p	N82H	0	.	.	244	246	AAT	598	600	AAT	21;21;21	A;A;T	21;21;21	tetR.3003479.AL513383.179218_179845.2090:1:1:N82H:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.manually_added_J01830_AAB59093.1_903_1526	tetR.manually_added_J01830_AAB59093.1_903_1526	1	0	27	230	tetR_1	624	624	100.0	tetR_1.l15.c17.ctg.1	1284	13.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	806	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	2138	27.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
